BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17372568)

  • 1. Radiolanthanide complexes with tetraazamacrocycles bearing methylphosphonate pendant arms as bone seeking agents.
    Gano L; Marques F; Campello MP; Balbina M; Lacerda S; Santos I
    Q J Nucl Med Mol Imaging; 2007 Mar; 51(1):6-15. PubMed ID: 17372568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 13- and 14-membered macrocyclic ligands containing methylcarboxylate or methylphosphonate pendant arms: chemical and biological evaluation of their (153)Sm and (166)Ho complexes as potential agents for therapy or bone pain palliation.
    Marques F; Gano L; Paula Campello M; Lacerda S; Santos I; Lima LM; Costa J; Antunes P; Delgado R
    J Inorg Biochem; 2006 Feb; 100(2):270-80. PubMed ID: 16387365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 153Sm and 166Ho complexes with tetraaza macrocycles containing pyridine and methylcarboxylate or methylphosphonate pendant arms.
    Marques F; Guerra KP; Gano L; Costa J; Campello MP; Lima LM; Delgado R; Santos I
    J Biol Inorg Chem; 2004 Oct; 9(7):859-72. PubMed ID: 15338314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel tetraazamacrocycle bearing a thiol pendant arm for labeling biomolecules with radiolanthanides.
    Lacerda S; Campello MP; Marques F; Gano L; Kubícek V; Fousková P; Tóth E; Santos I
    Dalton Trans; 2009 Jun; (23):4509-18. PubMed ID: 19488449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of (166)Dy/(166)Ho-EDTMP: a potential in vivo generator system for bone marrow ablation.
    Pedraza-López M; Ferro-Flores G; de Murphy CA; Tendilla JI; Villanueva-Sánchez O
    Nucl Med Commun; 2004 Jun; 25(6):615-21. PubMed ID: 15167523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [166Dy]Dy/166Ho hydroxide macroaggregates: an in vivo generator system for radiation synovectomy.
    Ferro-Flores G; Hernández-Oviedo O; Arteaga de Murphy C; Tendilla JI; Monroy-Guzmán F; Pedraza-López M; Aldama-Alvarado K
    Appl Radiat Isot; 2004 Dec; 61(6):1227-33. PubMed ID: 15388114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo behavior of copper-64-labeled methanephosphonate tetraaza macrocyclic ligands.
    Sun X; Wuest M; Kovacs Z; Sherry AD; Motekaitis R; Wang Z; Martell AE; Welch MJ; Anderson CJ
    J Biol Inorg Chem; 2003 Jan; 8(1-2):217-25. PubMed ID: 12459917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TETA analogue containing one methylenephosphonate pendant arm: Lanthanide complexes and biological evaluation of its 153Sm and 166Ho complexes.
    Lima LM; Delgado R; Marques F; Gano L; Santos I
    Eur J Med Chem; 2010 Dec; 45(12):5621-7. PubMed ID: 20888085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethylene diamine tetramethylene phosphonic acid labeled with various β(-)-emitting radiometals: labeling optimization and animal biodistribution.
    Sohaib M; Ahmad M; Jehangir M; Perveen A
    Cancer Biother Radiopharm; 2011 Apr; 26(2):159-64. PubMed ID: 21510750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of cyclotron-produced 186Re and comparison with reactor-produced 186Re and generator-produced 188Re for the labeling of bombesin.
    Moustapha ME; Ehrhardt GJ; Smith CJ; Szajek LP; Eckelman WC; Jurisson SS
    Nucl Med Biol; 2006 Jan; 33(1):81-9. PubMed ID: 16459262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and preliminary biological evaluation of a novel 109Pd labeled porphyrin derivative for possible use in targeted tumor therapy.
    Chakraborty S; Das T; Banerjee S; Sarma HD; Venkatesh M
    Q J Nucl Med Mol Imaging; 2007 Mar; 51(1):16-23. PubMed ID: 17372569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical and biological evaluation of 153Sm and 166Ho complexes of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylphosphonic acid monoethylester) (H4 dotp OEt).
    Försterová M; Jandurová Z; Marques F; Gano L; Lubal P; Vanek J; Hermann P; Santos I
    J Inorg Biochem; 2008 Jul; 102(7):1531-40. PubMed ID: 18374985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and biological evaluation of 111In-, 177Lu- and 90Y-labeled DOTA analogues conjugated to B72.3.
    Mohsin H; Fitzsimmons J; Shelton T; Hoffman TJ; Cutler CS; Lewis MR; Athey PS; Gulyas G; Kiefer GE; Frank RK; Simon J; Lever SZ; Jurisson SS
    Nucl Med Biol; 2007 Jul; 34(5):493-502. PubMed ID: 17591549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiolanthanide-labeled monoclonal antibody CC49 for radioimmunotherapy of cancer: biological comparison of DOTA conjugates and 149Pm, 166Ho, and 177Lu.
    Mohsin H; Jia F; Sivaguru G; Hudson MJ; Shelton TD; Hoffman TJ; Cutler CS; Ketring AR; Athey PS; Simón J; Frank RK; Jurisson SS; Lewis MR
    Bioconjug Chem; 2006; 17(2):485-92. PubMed ID: 16536481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 212Bi-DOTMP: an alpha particle emitting bone-seeking agent for targeted radiotherapy.
    Hassfjell SP; Bruland OS; Hoff P
    Nucl Med Biol; 1997 Apr; 24(3):231-7. PubMed ID: 9228657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a new biotin-DOTA conjugate for pretargeted antibody-guided radioimmunotherapy (PAGRIT).
    Urbano N; Papi S; Ginanneschi M; De Santis R; Pace S; Lindstedt R; Ferrari L; Choi S; Paganelli G; Chinol M
    Eur J Nucl Med Mol Imaging; 2007 Jan; 34(1):68-77. PubMed ID: 16755333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of an in vitro model for assessing the in vivo stability of lanthanide chelates.
    Li WP; Ma DS; Higginbotham C; Hoffman T; Ketring AR; Cutler CS; Jurisson SS
    Nucl Med Biol; 2001 Feb; 28(2):145-54. PubMed ID: 11295425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrazolyl derivatives as bifunctional chelators for labeling tumor-seeking peptides with the fac-[M(CO)3]+ moiety (M = 99mTc, Re): synthesis, characterization, and biological behavior.
    Alves S; Paulo A; Correia JD; Gano L; Smith CJ; Hoffman TJ; Santos I
    Bioconjug Chem; 2005; 16(2):438-49. PubMed ID: 15769099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiolabelling morpholinos with 188Re tricarbonyl provides improved in vitro and in vivo stability to re-oxidation.
    He J; Liu C; Vanderheyden JL; Liu G; Dou S; Rusckowski M; Hnatowich DJ
    Nucl Med Commun; 2004 Jul; 25(7):731-6. PubMed ID: 15208502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 175Yb-labeled hydroxyapatite: a potential agent for use in radiation synovectomy of small joints.
    Chakraborty S; Das T; Banerjee S; Subramanian S; Sarma HD; Venkatesh M
    Nucl Med Biol; 2006 May; 33(4):585-91. PubMed ID: 16720253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.